New pill for weight loss? early safety trial underway
NCT ID NCT05313802
First seen May 27, 2026 · Last updated Jun 23, 2026 · Updated 5 times
Summary
This completed Phase 1 trial tested an oral drug called LY3502970 in 72 healthy overweight and obese adults. The main goal was to check safety and how the body handles the drug. Participants took the drug by mouth and were monitored for up to 42 days. Results will help decide if further studies are warranted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Early Phase Services
San Antonio, Texas, 78209, United States
-
ICON Early Phase Services Lenexa Center
Lenexa, Kansas, 66219, United States
-
Qps-Mra, Llc
Miami, Florida, 33143, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LY3502970 (oral drug)
What this could lead to
If successful, this could lead to a new oral medication for weight management.
What could go wrong
This is an early Phase 1 trial focused on safety, not effectiveness. The drug may not work for weight loss or could have side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.